Daewoong Pharmaceutical logo

Daewoong Pharmaceutical

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Daewoong Pharmaceutical is a healthcare company that provides pharmaceuticals solutions and services for consumers.

Investor Profile

Daewoong Pharmaceutical has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, South Korea.
  • Strong thematic focus on Biotechnology, Genetics, Health Care.

Stage Focus

  • Series Unknown (50%)
  • Series A (50%)

Country Focus

  • United States (50%)
  • South Korea (50%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Life Science
  • Therapeutics
  • Food Processing
  • Livestock
  • Meat And Poultry
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Daewoong Pharmaceutical frequently co-invest with?

Shanda Group
North America, California, United States, Menlo Park
Co-Investments: 1
ThreeD Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
HanAll Biopharma
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
MF
North America, Virginia, United States, Springfield
Co-Investments: 1
BV
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
Genting Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Daewoong Pharmaceutical?

CellMEAT

Gwangju, Kwangju-jikhalsi, South Korea

CellMEAT is a company that provides protein production services.

Food ProcessingLivestockMeat and Poultry
Series AMay 24, 2023
Amount Raised: $13,193,628
Turn.bio

Mountain View, California, United States

Turn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases.

BiotechnologyGeneticsHealth CareLife ScienceTherapeutics
Series UnknownApr 11, 2022